Wednesday, 30 October 2019

FDA approves Biogen and Alkermes' multiple sclerosis drug

The U.S. Food and Drug Administration approved Biogen Inc and partner Alkermes Plc's oral drug to treat multiple sclerosis, the companies said on Wednesday.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)